Efficacy and cost-effectiveness of consensus interferon monotherapy with high-dose induction for hepatitis C patients with genotype 2

By Iwasaki Yoshiaki   Tanaka Hironori   Ikeada Hiroshi   Okamoto Ryo-ichi   Araki Yasuyuki   Yabushita Kazuhisa   Kobashi Haruhiko   Kariyama Kazuya   Kawaguchi Mitsuhiko   Takaguchi Kouichi   Sakata Tatsuro   Ando Masaharu   Sakaguchi Kohsaku   Aoki Noriaki   Shiratori Yasushi  

Scandinavian Journal of Gastroenterology, Vol. 46, Iss. 1, 2011-01 ,pp. : 79-90

Informa Healthcare

Access to resources Recommend Favorite

Cost-effectiveness of Screening for Chronic Hepatitis C Infection in the United States

By Eckman Mark H.   Talal Andrew H.   Gordon Stuart C.   Schiff Eugene   Sherman Kenneth E.  

Clinical Infectious Diseases, Vol. 56, Iss. 10, 2013-05 ,pp. : 1382-1393

Oxford University Press

Access to resources Recommend Favorite

Clinical Benefits and Cost-Effectiveness of 17-Year Treatment with Low-Dose Interferon-α 2b in a Patient with Chronic Hepatitis C: A Case Report

By Kawaguchi Takumi   Sumie Shuji   Itou Minoru   Taniguchi Eitaro   Matoba Tsunetaka   Sata Michio  

Digestive Diseases and Sciences, Vol. 54, Iss. 3, 2009-03 ,pp. : 690-694

Springer Publishing Company

Access to resources Recommend Favorite

Cost-effectiveness of Interferon Alfa-2b With and Without Ribavirin as Therapy for Chronic Hepatitis C in Sweden

By Sennfält K.   Reichard O.   Hultkrantz R.   Wong J. B.   Jonsson D.  

Scandinavian Journal of Gastroenterology, Vol. 36, Iss. 8, 2001-08 ,pp. : 870-876

Informa Healthcare

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Thrombolytic Treatment for Stroke

By  

Cerebrovascular Diseases, Vol. 20, Iss. 3, 2005-09 ,pp. : 193-200

Karger

Access to resources Recommend Favorite